Head-to-head · Value Score
bmiMD vs BetterMe Rx
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, BetterMe Rx a 86. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#8 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameBetterMe Rx
#16 · Grade A- · Great Deal
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 86 — an est. $99/mo first month, with no teaser step-up baked in. BetterMe Rx isn't out of it: App-first shoppers who want a verified pharmacy and an oral route instead of weekly injections.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | BetterMe Rx |
|---|---|---|
| Value Score | 89 (A) | 86 (A-) |
| Est. first month | $99/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $139/mo | $299/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
BetterMe Rx
A LegitScript-certified, all-50-state program pairing standard $199/$299 flat pricing with a lower-cost oral option.
Why it's a deal
- LegitScript-certified with all-50-state reach
- Offers an oral/sublingual route at a lower entry
- Flat pricing on both molecules — no step-up
The fine print
- $199/$299 is mid-market, not a bargain
- No brand-name access
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.